The CAST RR-Interval Substudy Database

• Epstein AE, Bigger JT Jr, Wyse DG, Romhilt DW, Reynolds-Haertle RA, Hallstrom AP. Events in the Cardiac Arrhythmia Suppression Trial (CAST): mortality in the entire population enrolled. J Am Coll Cardiol 1991 Jul;18(1):14-19. Erratum in: J Am Coll Cardiol 1991 Sep;18(3):888. [Abstract]

• Echt DS, Liebson PR, Mitchell LB, Peters RW, Obias-Manno D, Barker AH, Arensberg D, Baker A, Friedman L, Greene HL, Richardson DW, and the CAST Investigators. Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial. N Engl J Med 1991 Mar 21;324(12):781-8. Comment in N Engl J Med 1991 Aug 22;325(8):584-5. Comment in N Engl J Med 1992 Dec 17;327(25):1818. [Abstract]

• The Cardiac Arrhythmia Suppression Trial II Investigators. Effect of the antiarrhythmic agent moricizine on survival after myocardial infraction. N Engl J Med 1992 Jul;327:227-33. [Abstract]

• Hallstrom A, Pratt CM, Greene HL, Huther M, Gottlieb S, DeMaria A, Young JB. Relations between heart failure, ejection fraction, arrhythmia suppression and mortality: analysis of the Cardiac Arrhythmia Suppression Trial. J Am Coll Cardiol 1995 May;25(6):1250-7. [Abstract]

• Stein PK, Domitrovich PP, Kleiger RE, Schechtman KB, Rottman JN. Clinical and demographic determinants of heart rate variability in patients post myocardial infarction: insights from the Cardiac Arrhythmia Suppression Trial (CAST). Clin Cardiol 2000 Mar;23(3):187-94. [Abstract]

• Stein PK, Domitrovich PP, Kleiger RE; CAST Investigators. Including patients with diabetes mellitus or coronary artery bypass grafting decreases the association between heart rate variability and mortality after myocardial infarction. Am Heart J 2004 Feb;147(2):309-16. [Abstract]

Many additional publications that discuss the CAST and CAST II studies are listed here.

CRISDB home

Your comments and suggestions are welcome. We encourage you to use our feedback form to comment on this page. If you would like to receive a reply, please send your comments by email to webmaster@physionet.org, or post them to: PhysioNet MIT Room E25-505A 77 Massachusetts Avenue Cambridge, MA 02139 USA

Updated Monday, 05-Nov-2007 13:05:34 EST